136 related articles for article (PubMed ID: 12572844)
21. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
Mittag M; Beckheinrich P; Haustein UF
Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
[TBL] [Abstract][Full Text] [Related]
22. Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Curr Neurovasc Res; 2007 Feb; 4(1):55-62. PubMed ID: 17311545
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
[TBL] [Abstract][Full Text] [Related]
24. Adhesion molecules in different treatments of acute myocardial infarction.
Kerner T; Ahlers O; Reschreiter H; Bührer C; Möckel M; Gerlach H
Crit Care; 2001; 5(3):145-50. PubMed ID: 11353931
[TBL] [Abstract][Full Text] [Related]
25. Endothelial expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 is suppressed by postbypass plasma containing increased soluble intercellular adhesion molecule 1 and vascular cell adhesion molecule 1.
Vallely MP; Bannon PG; Hughes CF; Kritharides L
J Thorac Cardiovasc Surg; 2002 Oct; 124(4):758-67. PubMed ID: 12324734
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy.
Chen KH; Chien Y; Wang KL; Leu HB; Hsiao CY; Lai YH; Wang CY; Chang YL; Lin SJ; Niu DM; Chiou SH; Yu WC
Can J Cardiol; 2016 Oct; 32(10):1221.e1-1221.e9. PubMed ID: 26919792
[TBL] [Abstract][Full Text] [Related]
28. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure.
Whalen MJ; Doughty LA; Carlos TM; Wisniewski SR; Kochanek PM; Carcillo JA
Crit Care Med; 2000 Jul; 28(7):2600-7. PubMed ID: 10921602
[TBL] [Abstract][Full Text] [Related]
29. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia.
Krauss T; Kuhn W; Lakoma C; Augustin HG
Am J Obstet Gynecol; 1997 Aug; 177(2):443-9. PubMed ID: 9290466
[TBL] [Abstract][Full Text] [Related]
30. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
[TBL] [Abstract][Full Text] [Related]
31. Soluble adhesion molecules and unstable coronary artery disease.
Parker C; Vita JA; Freedman JE
Atherosclerosis; 2001 Jun; 156(2):417-24. PubMed ID: 11395039
[TBL] [Abstract][Full Text] [Related]
32. Cytokines and soluble cell adhesion molecules. Possible markers of inflammatory response in atherosclerosis.
Teplyakov AI; Pryschepova EV; Kruchinsky NG; Chegerova TI
Ann N Y Acad Sci; 2000 May; 902():320-2. PubMed ID: 10865856
[No Abstract] [Full Text] [Related]
33. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
[TBL] [Abstract][Full Text] [Related]
34. Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
Togawa T; Kodama T; Suzuki T; Sugawara K; Tsukimura T; Ohashi T; Ishige N; Suzuki K; Kitagawa T; Sakuraba H
Mol Genet Metab; 2010 Jul; 100(3):257-61. PubMed ID: 20409739
[TBL] [Abstract][Full Text] [Related]
35. Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies.
Nissen JJ; Mantle D; Gregson B; Mendelow AD
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):329-33. PubMed ID: 11511705
[TBL] [Abstract][Full Text] [Related]
36. Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment.
Caproni M; Volpi W; Giomi B; Torchia D; Del Bianco E; Fabbri P
Br J Dermatol; 2006 Dec; 155(6):1270-4. PubMed ID: 17107400
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
38. Enzyme replacement therapy and renal function in 201 patients with Fabry disease.
Schwarting A; Dehout F; Feriozzi S; Beck M; Mehta A; Sunder-Plassmann G;
Clin Nephrol; 2006 Aug; 66(2):77-84. PubMed ID: 16939062
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.
Göke M; Hoffmann JC; Evers J; Krüger H; Manns MP
J Gastroenterol; 1997 Aug; 32(4):480-6. PubMed ID: 9250894
[TBL] [Abstract][Full Text] [Related]
40. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
Jacobson SH; Egberg N; Hylander B; Lundahl J
Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
